Trends in gene therapy approvals in recent years are rapidly shaping the future ...
After last year’s Nobel Prize in Physiology or Medicine was awarded to Drew Weis...
A large phase 3 study conducted over GSK’s RSV vaccine Arexvy has shown how the ...
Maven Clinic, an online clinic for women and family health, has closed its serie...
Regulators around the world are increasing their scrutiny of medical devices as ...
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen...
Starboard has accused Pfizer of “coercive conduct” after executives who initiall...
Booster Therapeutics has announced its inception to develop a new class of prote...
KeyBioscience and Eli Lilly have extended their partnership to develop a new cla...
High-concentration monoclonal antibodies (mAbs) are gaining prominence given the...
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for ...
The Cardiovascular and Renal Drugs Advisory Committee voted 10-6 in support of S...
Plaque psoriasis is a chronic condition that affects millions yet is often misun...
The US FDA approved Itovebi in combination with Pfizer’s Ibrance and AstraZeneca...
Scholar Rock Inc has announced that the phase 3 trial of Apitegromab for spinal ...
